^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Chronic Myeloid Leukemia |
| Drug: | busulfan (Alkylating agent) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
12/24/2003
Excerpt:
MYLERAN (busulfan) is indicated for the palliative treatment of chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia.
